
The IMMCG Newsroom is your hub for the latest news, stories, and media coverage from the Immunology Center of Georgia (IMMCG), part of the Medical College of Georgia at Augusta University. Here you’ll find recent Jagwire articles, public‑facing newsletters, and an “In the News” section highlighting external media coverage featuring our scientists and trainees, along with videos from our YouTube channel. Check back often to stay up to date on the people, discoveries, and events shaping IMMCG.



Top 6 stories:
A groundbreaking discovery published in Nature Immunology has shed light on why the immune system is less aggressive toward self-antigens, offering new opportunities to enhance cancer immunotherapy.
Read full story: Expanse Supercomputer Used for Breakthrough Immunotherapy StudyA researcher at Augusta University’s Immunology Center of Georgia has been awarded the center’s first American Heart Association Postdoctoral Fellowship to support innovative research into the link between cancer and cardiovascular disease.
Read full story: Augusta University researcher receives grant to study link between cancer, cardiovascular diseaseRussell Keen, president of Augusta University, presided over the opening of AU-Medical College of Georgia’s Savannah campus, increasing enrollment and moving the school into the top five in the nation for class size.
Read full story: Augusta University | Healthcare Workforce: A Prescription for the FutureRafael Czepielewski, PhD, at the Immunology Center of Georgia, received the MIST Scholar Award from the NIH to fund research on the interplay between the immune system and lymphatic vasculature in chronic conditions.
Read full story: AU immunologist earns NIH grant to study chronic inflammatory diseasesEach year, 13 million Americans become infected with HPV. While most show no symptoms, at least a dozen types can lead to cancer, causing 36,000 cases in the United States annually.
Read full story: The HPV breakdown: Why you should 'Gard' your healthIn a recent Nature Immunology publication, researchers explored the mechanisms responsible for the limited immune response to self-antigens, even upon vaccination, essential for preventing autoreactivity.
Read full story: CD73 and PD-1 gatekeep self-reactive CD4+ T cell expansion| Year | Spring/Fall | Newsletters |
| 2025 | Fall | *newest* NEWSLETTER |
| 2025 | Spring | NEWSLETTER |
| 2024 | Fall | NEWSLETTER |
| 2024 | Spring | NEWSLETTER |